Results of a phase III trial of IM recombinant beta interferon as treatment for MS
- 31 October 1994
- journal article
- abstracts
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 54 (1) , 170
- https://doi.org/10.1016/0165-5728(94)90370-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: